Specify a stock or a cryptocurrency in the search bar to get a summary
Achieve Life Sciences Inc
ACHVAchieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada. Address: 1040 West Georgia Street, Vancouver, BC, Canada, V6E 4H1
Analytics
WallStreet Target Price
17.25 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ACHV
Dividend Analytics ACHV
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ACHV
Stock Valuation ACHV
Financials ACHV
Results | 2019 | Dynamics |